- Home
- TPVG vs BNTC Comparison
TPVG vs BNTC Comparison
Compare TPVG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPVG
- BNTC
- Stock Information
- Founded
- TPVG 2013
- BNTC 1995
- Country
- TPVG United States
- BNTC United States
- Employees
- TPVG N/A
- BNTC N/A
- Industry
- TPVG Other Consumer Services
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- TPVG Consumer Discretionary
- BNTC Health Care
- Exchange
- TPVG Nasdaq
- BNTC Nasdaq
- Market Cap
- TPVG 242.0M
- BNTC 352.5M
- IPO Year
- TPVG N/A
- BNTC N/A
- Fundamental
- Price
- TPVG $6.30
- BNTC $13.74
- Analyst Decision
- TPVG Hold
- BNTC Strong Buy
- Analyst Count
- TPVG 6
- BNTC 7
- Target Price
- TPVG $6.55
- BNTC $24.71
- AVG Volume (30 Days)
- TPVG 326.1K
- BNTC 37.1K
- Earning Date
- TPVG 05-07-2025
- BNTC 05-16-2025
- Dividend Yield
- TPVG 19.02%
- BNTC N/A
- EPS Growth
- TPVG N/A
- BNTC N/A
- EPS
- TPVG 0.93
- BNTC N/A
- Revenue
- TPVG $101,389,000.00
- BNTC N/A
- Revenue This Year
- TPVG N/A
- BNTC N/A
- Revenue Next Year
- TPVG $5.01
- BNTC N/A
- P/E Ratio
- TPVG $6.82
- BNTC N/A
- Revenue Growth
- TPVG N/A
- BNTC N/A
- 52 Week Low
- TPVG $5.53
- BNTC $5.74
- 52 Week High
- TPVG $9.70
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- TPVG 50.94
- BNTC 51.06
- Support Level
- TPVG $5.87
- BNTC $13.10
- Resistance Level
- TPVG $6.18
- BNTC $15.69
- Average True Range (ATR)
- TPVG 0.18
- BNTC 0.73
- MACD
- TPVG 0.05
- BNTC -0.01
- Stochastic Oscillator
- TPVG 88.33
- BNTC 24.71
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.